Thomas LN, Merrimen J, Bell DG, Rendon R, Goffin V, Too CK. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting. Prostate. 2014 May;74(7):732–42. doi: 10.1002/pros.22793. PMID: 24615730.